Kaiser Permanente, San Diego, California, USA.
Ann Allergy Asthma Immunol. 2010 Feb;104(2):118-24. doi: 10.1016/j.anai.2009.11.063.
Allergic rhinitis is common, but a validated tool for comprehensive assessment of disease control is not available.
To develop a simple patient-completed instrument (the Rhinitis Control Assessment Test [RCAT]) to help detect problems with control of rhinitis symptoms.
During a visit to an allergy specialist, 410 patients with allergic rhinitis completed a Total Nasal Symptom Score (TNSS) assessment and the 26-item developmental RCAT. Physicians also completed a global assessment of rhinitis symptom control for each patient.
Stepwise regression methods identified 6 items from the developmental RCAT (frequency of nasal congestion, sneezing, and watery eyes; sleep interference; activity avoidance; and self-assessed control) that were most predictive of the allergist's global rating of rhinitis symptom control. A summated rating scale from these 6 items showed good convergent validity (r > 0.70) with scale scores from the TNSS. The discriminant validity of the 6-item scale was demonstrated as mean RCAT scale scores differed significantly across groups of patients differing in physician-rated disease severity (F = 54.4), TNSS severity (F = 193.8), and physician-recommended change in therapy (F = 50.6) (P < .001 for all).
The RCAT, a 6-item patient-completed instrument, has satisfactory psychometric properties and seems to be a valid tool for assessing control of allergic rhinitis. Further validation studies will provide confirmation.
变应性鼻炎很常见,但目前仍缺乏一种全面评估疾病控制情况的有效工具。
开发一种简单的患者自评工具(鼻炎控制评估测试,RCAT),以帮助发现鼻炎症状控制不佳的问题。
在过敏专科就诊时,410 例变应性鼻炎患者完成了总鼻症状评分(TNSS)评估和 26 项 RCAT 开发测试。医生还对每位患者的鼻炎症状控制情况进行了总体评估。
逐步回归方法从 RCAT 开发测试中确定了 6 个项目(鼻塞、打喷嚏和流泪的频率、睡眠干扰、活动回避以及自我评估的控制情况),这些项目对过敏医生对鼻炎症状控制的总体评价最具预测性。这 6 个项目的综合评分与 TNSS 评分具有良好的相关性(r > 0.70)。6 项量表的判别效度也得到了验证,因为不同医生评估的疾病严重程度(F = 54.4)、TNSS 严重程度(F = 193.8)和医生建议的治疗改变(F = 50.6)的患者群体之间,RCAT 量表评分存在显著差异(P <.001)。
RCAT 是一种 6 项患者自评的工具,具有良好的心理测量学特性,似乎是评估变应性鼻炎控制情况的有效工具。进一步的验证研究将提供确认。